English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 124 | Tables: 124 | Medical Care
The global Melasma Treatments market was valued at US$ 6750 million in 2025 and is anticipated to reach US$ 17428 million by 2032, at a CAGR of 16.0% from 2026 to 2032.
Melasma treatments refer to medical interventions used to improve and manage facial hyperpigmentation associated with melasma, primarily including pharmaceutical therapies (topical prescription drugs and oral adjunctive medications) and aesthetic medical procedures (such as chemical peels and laser/light-based treatments). The market is characterized by combination therapy, long treatment cycles, and high recurrence rates, making it a recurring and hybrid medical-consumption market.
The main driver of the melasma treatment market is the chronic and relapsing nature of the condition, which creates sustained demand for repeated treatments over time. In addition, advancements in aesthetic technologies—such as picosecond lasers and low-energy combination therapies—have improved both efficacy and safety, encouraging patients to adopt integrated treatment approaches combining pharmaceuticals and procedures. Furthermore, rising aesthetic awareness in regions such as Asia, the Middle East, and Latin America, along with increasing penetration of aesthetic clinics, is accelerating the shift from purely medical treatment toward a hybrid medical-consumer market.
This report delivers a comprehensive overview of the global Melasma Treatments market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Melasma Treatments. The Melasma Treatments market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Melasma Treatments market comprehensively. Regional market sizes by Type, by Channel, by Therapy Modality, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Melasma Treatments manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Channel, and by region.
Market Segmentation
By Company
Galderma
FONOW
Obagi Cosmeceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s Laboratories
Almirall
Bausch Health
AbbVie
Teva Pharmaceutical Industries
Cutis Medical Laser Clinics
Ensoul Medical Clinic
The Ogee Clinic
Edwin Lim Medical Aesthetic Clinic
Veritas Clinic
Beaucare Clinics (BCC)
MYLIKE
Yestar
ARSMO
Segment by Type
Pharmaceutical Treatments
Aesthetic Procedures
Combination Therapies
Segment by Therapy Modality
Topical Therapy
Oral Therapy
Chemical Peels
Laser and Light-based Therapy
Segment by Age of Customer
Under 25 Years Old
25–34 Years Old
35–44 Years Old
45+ Years Old
Segment by Channel
Hospitals
Beauty Salon
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Channel, by Therapy Modality, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Melasma Treatments companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Channel, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melasma Treatments Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Pharmaceutical Treatments
1.2.3 Aesthetic Procedures
1.2.4 Combination Therapies
1.3 Market by Therapy Modality
1.3.1 Global Melasma Treatments Market Size Growth Rate by Therapy Modality: 2021 vs 2025 vs 2032
1.3.2 Topical Therapy
1.3.3 Oral Therapy
1.3.4 Chemical Peels
1.3.5 Laser and Light-based Therapy
1.4 Market by Age of Customer
1.4.1 Global Melasma Treatments Market Size Growth Rate by Age of Customer: 2021 vs 2025 vs 2032
1.4.2 Under 25 Years Old
1.4.3 25–34 Years Old
1.4.4 35–44 Years Old
1.4.5 45+ Years Old
1.5 Market by Channel
1.5.1 Global Melasma Treatments Market Growth by Channel: 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Beauty Salon
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Melasma Treatments Market Perspective (2021–2032)
2.2 Global Melasma Treatments Growth Trends by Region
2.2.1 Global Melasma Treatments Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Melasma Treatments Historic Market Size by Region (2021–2026)
2.2.3 Melasma Treatments Forecasted Market Size by Region (2027–2032)
2.3 Melasma Treatments Market Dynamics
2.3.1 Melasma Treatments Industry Trends
2.3.2 Melasma Treatments Market Drivers
2.3.3 Melasma Treatments Market Challenges
2.3.4 Melasma Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melasma Treatments Players by Revenue
3.1.1 Global Top Melasma Treatments Players by Revenue (2021–2026)
3.1.2 Global Melasma Treatments Revenue Market Share by Players (2021–2026)
3.2 Global Top Melasma Treatments Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Melasma Treatments Revenue
3.4 Global Melasma Treatments Market Concentration Ratio
3.4.1 Global Melasma Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melasma Treatments Revenue in 2025
3.5 Global Key Players of Melasma Treatments Head Offices and Areas Served
3.6 Global Key Players of Melasma Treatments, Products and Applications
3.7 Global Key Players of Melasma Treatments, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Melasma Treatments Breakdown Data by Type
4.1 Global Melasma Treatments Historic Market Size by Type (2021–2026)
4.2 Global Melasma Treatments Forecasted Market Size by Type (2027–2032)
5 Melasma Treatments Breakdown Data by Channel
5.1 Global Melasma Treatments Historic Market Size by Channel (2021–2026)
5.2 Global Melasma Treatments Forecasted Market Size by Channel (2027–2032)
6 North America
6.1 North America Melasma Treatments Market Size (2021–2032)
6.2 North America Melasma Treatments Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Melasma Treatments Market Size by Country (2021–2026)
6.4 North America Melasma Treatments Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Melasma Treatments Market Size (2021–2032)
7.2 Europe Melasma Treatments Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Melasma Treatments Market Size by Country (2021–2026)
7.4 Europe Melasma Treatments Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Melasma Treatments Market Size (2021–2032)
8.2 Asia-Pacific Melasma Treatments Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Melasma Treatments Market Size by Region (2021–2026)
8.4 Asia-Pacific Melasma Treatments Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Melasma Treatments Market Size (2021–2032)
9.2 Latin America Melasma Treatments Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Melasma Treatments Market Size by Country (2021–2026)
9.4 Latin America Melasma Treatments Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melasma Treatments Market Size (2021–2032)
10.2 Middle East & Africa Melasma Treatments Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Melasma Treatments Market Size by Country (2021–2026)
10.4 Middle East & Africa Melasma Treatments Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Details
11.1.2 Galderma Business Overview
11.1.3 Galderma Melasma Treatments Introduction
11.1.4 Galderma Revenue in Melasma Treatments Business (2021–2026)
11.1.5 Galderma Recent Development
11.2 FONOW
11.2.1 FONOW Company Details
11.2.2 FONOW Business Overview
11.2.3 FONOW Melasma Treatments Introduction
11.2.4 FONOW Revenue in Melasma Treatments Business (2021–2026)
11.2.5 FONOW Recent Development
11.3 Obagi Cosmeceuticals
11.3.1 Obagi Cosmeceuticals Company Details
11.3.2 Obagi Cosmeceuticals Business Overview
11.3.3 Obagi Cosmeceuticals Melasma Treatments Introduction
11.3.4 Obagi Cosmeceuticals Revenue in Melasma Treatments Business (2021–2026)
11.3.5 Obagi Cosmeceuticals Recent Development
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Details
11.4.2 Glenmark Pharmaceuticals Business Overview
11.4.3 Glenmark Pharmaceuticals Melasma Treatments Introduction
11.4.4 Glenmark Pharmaceuticals Revenue in Melasma Treatments Business (2021–2026)
11.4.5 Glenmark Pharmaceuticals Recent Development
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Details
11.5.2 Sun Pharmaceutical Industries Business Overview
11.5.3 Sun Pharmaceutical Industries Melasma Treatments Introduction
11.5.4 Sun Pharmaceutical Industries Revenue in Melasma Treatments Business (2021–2026)
11.5.5 Sun Pharmaceutical Industries Recent Development
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Company Details
11.6.2 Dr. Reddy’s Laboratories Business Overview
11.6.3 Dr. Reddy’s Laboratories Melasma Treatments Introduction
11.6.4 Dr. Reddy’s Laboratories Revenue in Melasma Treatments Business (2021–2026)
11.6.5 Dr. Reddy’s Laboratories Recent Development
11.7 Almirall
11.7.1 Almirall Company Details
11.7.2 Almirall Business Overview
11.7.3 Almirall Melasma Treatments Introduction
11.7.4 Almirall Revenue in Melasma Treatments Business (2021–2026)
11.7.5 Almirall Recent Development
11.8 Bausch Health
11.8.1 Bausch Health Company Details
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Melasma Treatments Introduction
11.8.4 Bausch Health Revenue in Melasma Treatments Business (2021–2026)
11.8.5 Bausch Health Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Melasma Treatments Introduction
11.9.4 AbbVie Revenue in Melasma Treatments Business (2021–2026)
11.9.5 AbbVie Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Details
11.10.2 Teva Pharmaceutical Industries Business Overview
11.10.3 Teva Pharmaceutical Industries Melasma Treatments Introduction
11.10.4 Teva Pharmaceutical Industries Revenue in Melasma Treatments Business (2021–2026)
11.10.5 Teva Pharmaceutical Industries Recent Development
11.11 Cutis Medical Laser Clinics
11.11.1 Cutis Medical Laser Clinics Company Details
11.11.2 Cutis Medical Laser Clinics Business Overview
11.11.3 Cutis Medical Laser Clinics Melasma Treatments Introduction
11.11.4 Cutis Medical Laser Clinics Revenue in Melasma Treatments Business (2021–2026)
11.11.5 Cutis Medical Laser Clinics Recent Development
11.12 Ensoul Medical Clinic
11.12.1 Ensoul Medical Clinic Company Details
11.12.2 Ensoul Medical Clinic Business Overview
11.12.3 Ensoul Medical Clinic Melasma Treatments Introduction
11.12.4 Ensoul Medical Clinic Revenue in Melasma Treatments Business (2021–2026)
11.12.5 Ensoul Medical Clinic Recent Development
11.13 The Ogee Clinic
11.13.1 The Ogee Clinic Company Details
11.13.2 The Ogee Clinic Business Overview
11.13.3 The Ogee Clinic Melasma Treatments Introduction
11.13.4 The Ogee Clinic Revenue in Melasma Treatments Business (2021–2026)
11.13.5 The Ogee Clinic Recent Development
11.14 Edwin Lim Medical Aesthetic Clinic
11.14.1 Edwin Lim Medical Aesthetic Clinic Company Details
11.14.2 Edwin Lim Medical Aesthetic Clinic Business Overview
11.14.3 Edwin Lim Medical Aesthetic Clinic Melasma Treatments Introduction
11.14.4 Edwin Lim Medical Aesthetic Clinic Revenue in Melasma Treatments Business (2021–2026)
11.14.5 Edwin Lim Medical Aesthetic Clinic Recent Development
11.15 Veritas Clinic
11.15.1 Veritas Clinic Company Details
11.15.2 Veritas Clinic Business Overview
11.15.3 Veritas Clinic Melasma Treatments Introduction
11.15.4 Veritas Clinic Revenue in Melasma Treatments Business (2021–2026)
11.15.5 Veritas Clinic Recent Development
11.16 Beaucare Clinics (BCC)
11.16.1 Beaucare Clinics (BCC) Company Details
11.16.2 Beaucare Clinics (BCC) Business Overview
11.16.3 Beaucare Clinics (BCC) Melasma Treatments Introduction
11.16.4 Beaucare Clinics (BCC) Revenue in Melasma Treatments Business (2021–2026)
11.16.5 Beaucare Clinics (BCC) Recent Development
11.17 MYLIKE
11.17.1 MYLIKE Company Details
11.17.2 MYLIKE Business Overview
11.17.3 MYLIKE Melasma Treatments Introduction
11.17.4 MYLIKE Revenue in Melasma Treatments Business (2021–2026)
11.17.5 MYLIKE Recent Development
11.18 Yestar
11.18.1 Yestar Company Details
11.18.2 Yestar Business Overview
11.18.3 Yestar Melasma Treatments Introduction
11.18.4 Yestar Revenue in Melasma Treatments Business (2021–2026)
11.18.5 Yestar Recent Development
11.19 ARSMO
11.19.1 ARSMO Company Details
11.19.2 ARSMO Business Overview
11.19.3 ARSMO Melasma Treatments Introduction
11.19.4 ARSMO Revenue in Melasma Treatments Business (2021–2026)
11.19.5 ARSMO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Melasma Treatments Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Pharmaceutical Treatments
Table 3. Key Players of Aesthetic Procedures
Table 4. Key Players of Combination Therapies
Table 5. Global Melasma Treatments Market Size Growth Rate by Therapy Modality (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Topical Therapy
Table 7. Key Players of Oral Therapy
Table 8. Key Players of Chemical Peels
Table 9. Key Players of Laser and Light-based Therapy
Table 10. Global Melasma Treatments Market Size Growth Rate by Age of Customer (US$ Million): 2021 vs 2025 vs 2032
Table 11. Key Players of Under 25 Years Old
Table 12. Key Players of 25–34 Years Old
Table 13. Key Players of 35–44 Years Old
Table 14. Key Players of 45+ Years Old
Table 15. Global Melasma Treatments Market Size Growth by Channel (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Melasma Treatments Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Melasma Treatments Market Size by Region (US$ Million), 2021–2026
Table 18. Global Melasma Treatments Market Share by Region (2021–2026)
Table 19. Global Melasma Treatments Forecasted Market Size by Region (US$ Million), 2027–2032
Table 20. Global Melasma Treatments Market Share by Region (2027–2032)
Table 21. Melasma Treatments Market Trends
Table 22. Melasma Treatments Market Drivers
Table 23. Melasma Treatments Market Challenges
Table 24. Melasma Treatments Market Restraints
Table 25. Global Melasma Treatments Revenue by Players (US$ Million), 2021–2026
Table 26. Global Melasma Treatments Market Share by Players (2021–2026)
Table 27. Global Top Melasma Treatments Players by Tier (Tier 1, Tier 2, and Tier 3), based on Melasma Treatments Revenue, 2025
Table 28. Ranking of Global Top Melasma Treatments Companies by Revenue (US$ Million) in 2025
Table 29. Global 5 Largest Players Market Share by Melasma Treatments Revenue (CR5 and HHI), 2021–2026
Table 30. Global Key Players of Melasma Treatments, Headquarters and Area Served
Table 31. Global Key Players of Melasma Treatments, Products and Applications
Table 32. Global Key Players of Melasma Treatments, Date of General Availability (GA)
Table 33. Mergers and Acquisitions, Expansion Plans
Table 34. Global Melasma Treatments Market Size by Type (US$ Million), 2021–2026
Table 35. Global Melasma Treatments Revenue Market Share by Type (2021–2026)
Table 36. Global Melasma Treatments Forecasted Market Size by Type (US$ Million), 2027–2032
Table 37. Global Melasma Treatments Revenue Market Share by Type (2027–2032)
Table 38. Global Melasma Treatments Market Size by Channel (US$ Million), 2021–2026
Table 39. Global Melasma Treatments Revenue Market Share by Channel (2021–2026)
Table 40. Global Melasma Treatments Forecasted Market Size by Channel (US$ Million), 2027–2032
Table 41. Global Melasma Treatments Revenue Market Share by Channel (2027–2032)
Table 42. North America Melasma Treatments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. North America Melasma Treatments Market Size by Country (US$ Million), 2021–2026
Table 44. North America Melasma Treatments Market Size by Country (US$ Million), 2027–2032
Table 45. Europe Melasma Treatments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Europe Melasma Treatments Market Size by Country (US$ Million), 2021–2026
Table 47. Europe Melasma Treatments Market Size by Country (US$ Million), 2027–2032
Table 48. Asia-Pacific Melasma Treatments Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 49. Asia-Pacific Melasma Treatments Market Size by Region (US$ Million), 2021–2026
Table 50. Asia-Pacific Melasma Treatments Market Size by Region (US$ Million), 2027–2032
Table 51. Latin America Melasma Treatments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Latin America Melasma Treatments Market Size by Country (US$ Million), 2021–2026
Table 53. Latin America Melasma Treatments Market Size by Country (US$ Million), 2027–2032
Table 54. Middle East & Africa Melasma Treatments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Middle East & Africa Melasma Treatments Market Size by Country (US$ Million), 2021–2026
Table 56. Middle East & Africa Melasma Treatments Market Size by Country (US$ Million), 2027–2032
Table 57. Galderma Company Details
Table 58. Galderma Business Overview
Table 59. Galderma Melasma Treatments Product
Table 60. Galderma Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 61. Galderma Recent Development
Table 62. FONOW Company Details
Table 63. FONOW Business Overview
Table 64. FONOW Melasma Treatments Product
Table 65. FONOW Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 66. FONOW Recent Development
Table 67. Obagi Cosmeceuticals Company Details
Table 68. Obagi Cosmeceuticals Business Overview
Table 69. Obagi Cosmeceuticals Melasma Treatments Product
Table 70. Obagi Cosmeceuticals Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 71. Obagi Cosmeceuticals Recent Development
Table 72. Glenmark Pharmaceuticals Company Details
Table 73. Glenmark Pharmaceuticals Business Overview
Table 74. Glenmark Pharmaceuticals Melasma Treatments Product
Table 75. Glenmark Pharmaceuticals Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 76. Glenmark Pharmaceuticals Recent Development
Table 77. Sun Pharmaceutical Industries Company Details
Table 78. Sun Pharmaceutical Industries Business Overview
Table 79. Sun Pharmaceutical Industries Melasma Treatments Product
Table 80. Sun Pharmaceutical Industries Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 81. Sun Pharmaceutical Industries Recent Development
Table 82. Dr. Reddy’s Laboratories Company Details
Table 83. Dr. Reddy’s Laboratories Business Overview
Table 84. Dr. Reddy’s Laboratories Melasma Treatments Product
Table 85. Dr. Reddy’s Laboratories Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 86. Dr. Reddy’s Laboratories Recent Development
Table 87. Almirall Company Details
Table 88. Almirall Business Overview
Table 89. Almirall Melasma Treatments Product
Table 90. Almirall Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 91. Almirall Recent Development
Table 92. Bausch Health Company Details
Table 93. Bausch Health Business Overview
Table 94. Bausch Health Melasma Treatments Product
Table 95. Bausch Health Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 96. Bausch Health Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Melasma Treatments Product
Table 100. AbbVie Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 101. AbbVie Recent Development
Table 102. Teva Pharmaceutical Industries Company Details
Table 103. Teva Pharmaceutical Industries Business Overview
Table 104. Teva Pharmaceutical Industries Melasma Treatments Product
Table 105. Teva Pharmaceutical Industries Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 106. Teva Pharmaceutical Industries Recent Development
Table 107. Cutis Medical Laser Clinics Company Details
Table 108. Cutis Medical Laser Clinics Business Overview
Table 109. Cutis Medical Laser Clinics Melasma Treatments Product
Table 110. Cutis Medical Laser Clinics Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 111. Cutis Medical Laser Clinics Recent Development
Table 112. Ensoul Medical Clinic Company Details
Table 113. Ensoul Medical Clinic Business Overview
Table 114. Ensoul Medical Clinic Melasma Treatments Product
Table 115. Ensoul Medical Clinic Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 116. Ensoul Medical Clinic Recent Development
Table 117. The Ogee Clinic Company Details
Table 118. The Ogee Clinic Business Overview
Table 119. The Ogee Clinic Melasma Treatments Product
Table 120. The Ogee Clinic Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 121. The Ogee Clinic Recent Development
Table 122. Edwin Lim Medical Aesthetic Clinic Company Details
Table 123. Edwin Lim Medical Aesthetic Clinic Business Overview
Table 124. Edwin Lim Medical Aesthetic Clinic Melasma Treatments Product
Table 125. Edwin Lim Medical Aesthetic Clinic Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 126. Edwin Lim Medical Aesthetic Clinic Recent Development
Table 127. Veritas Clinic Company Details
Table 128. Veritas Clinic Business Overview
Table 129. Veritas Clinic Melasma Treatments Product
Table 130. Veritas Clinic Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 131. Veritas Clinic Recent Development
Table 132. Beaucare Clinics (BCC) Company Details
Table 133. Beaucare Clinics (BCC) Business Overview
Table 134. Beaucare Clinics (BCC) Melasma Treatments Product
Table 135. Beaucare Clinics (BCC) Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 136. Beaucare Clinics (BCC) Recent Development
Table 137. MYLIKE Company Details
Table 138. MYLIKE Business Overview
Table 139. MYLIKE Melasma Treatments Product
Table 140. MYLIKE Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 141. MYLIKE Recent Development
Table 142. Yestar Company Details
Table 143. Yestar Business Overview
Table 144. Yestar Melasma Treatments Product
Table 145. Yestar Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 146. Yestar Recent Development
Table 147. ARSMO Company Details
Table 148. ARSMO Business Overview
Table 149. ARSMO Melasma Treatments Product
Table 150. ARSMO Revenue in Melasma Treatments Business (US$ Million), 2021–2026
Table 151. ARSMO Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 155. Authors List of This Report
List of Figures
Figure 1. Melasma Treatments Picture
Figure 2. Global Melasma Treatments Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Melasma Treatments Market Share by Type: 2025 vs 2032
Figure 4. Pharmaceutical Treatments Features
Figure 5. Aesthetic Procedures Features
Figure 6. Combination Therapies Features
Figure 7. Global Melasma Treatments Market Size Comparison by Therapy Modality (US$ Million), 2021–2032
Figure 8. Topical Therapy Features
Figure 9. Oral Therapy Features
Figure 10. Chemical Peels Features
Figure 11. Laser and Light-based Therapy Features
Figure 12. Global Melasma Treatments Market Size Comparison by Age of Customer (US$ Million), 2021–2032
Figure 13. Under 25 Years Old Features
Figure 14. 25–34 Years Old Features
Figure 15. 35–44 Years Old Features
Figure 16. 45+ Years Old Features
Figure 17. Global Melasma Treatments Market Size by Channel (US$ Million), 2021–2032
Figure 18. Global Melasma Treatments Market Share by Channel: 2025 vs 2032
Figure 19. Hospitals Case Studies
Figure 20. Beauty Salon Case Studies
Figure 21. Melasma Treatments Report Years Considered
Figure 22. Global Melasma Treatments Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 23. Global Melasma Treatments Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Melasma Treatments Market Share by Region: 2025 vs 2032
Figure 25. Global Melasma Treatments Market Share by Players in 2025
Figure 26. Global Melasma Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Melasma Treatments Revenue in 2025
Figure 28. North America Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. North America Melasma Treatments Market Share by Country (2021–2032)
Figure 30. United States Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Canada Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Melasma Treatments Market Share by Country (2021–2032)
Figure 34. Germany Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. France Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. U.K. Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Italy Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Russia Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Ireland Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Melasma Treatments Market Share by Region (2021–2032)
Figure 42. China Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Japan Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. South Korea Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Southeast Asia Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. India Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Australia & New Zealand Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Melasma Treatments Market Share by Country (2021–2032)
Figure 50. Mexico Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Brazil Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Melasma Treatments Market Share by Country (2021–2032)
Figure 54. Israel Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Saudi Arabia Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. UAE Melasma Treatments Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Galderma Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 58. FONOW Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 59. Obagi Cosmeceuticals Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 60. Glenmark Pharmaceuticals Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 61. Sun Pharmaceutical Industries Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 62. Dr. Reddy’s Laboratories Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 63. Almirall Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 64. Bausch Health Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 65. AbbVie Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 67. Cutis Medical Laser Clinics Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 68. Ensoul Medical Clinic Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 69. The Ogee Clinic Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 70. Edwin Lim Medical Aesthetic Clinic Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 71. Veritas Clinic Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 72. Beaucare Clinics (BCC) Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 73. MYLIKE Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 74. Yestar Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 75. ARSMO Revenue Growth Rate in Melasma Treatments Business (2021–2026)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
